OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer


Recommended Conferences for HEPATIC ENCEPHALOPATHY


As per available reports about 14 Relevant Journals, 03 Conferences are presently dedicated exclusively to Hepatic Encephalopathy and about 954 articles are being published on Hepatic Encephalopathy.

Hepatic encephalopathy or Portosystemic encephalopathy is the malfunction of brain that occurs due to liver failure. In advanced stages, it can cause a state called hepatic coma or coma hepatica and ultimately death. Though the exact causative of this disease is unknown, it has been determined that this disease is triggered by dehydration, high protein intake, low oxygen levels in the body, surgery, medicinal suppression of central nervous system, infections, bleeding of the intestines, esophagus, stomach, imbalance in electrolytes and liver diseases.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.          

Scope and Importance:

Treatment of Hepatitis is on the cutting edge of medicine. Hepatitis B virus infection (HBV) has been recognized as a major health problem worldwide and Hepatitis C virus (HCV) infection is the most common chronic blood borne infection in the United States. Viral hepatitis treatment depends on how active the virus is in your body. Viral hepatitis is the most common cause of hepatitis worldwide. Other causes of non-viral hepatitis include alcoholic hepatitis and autoimmune hepatitis.

Hepatic encephalopathy  is the occurrence of confusion, altered level of consciousness, and coma as a result of liver failure. It is caused by accumulation in the bloodstream of toxic substances that are normally removed by the liver. The diagnosis of hepatic encephalopathy requires the presence of impaired liver function and the exclusion of an alternative explanation for the symptoms. Blood tests (ammonia levels) may assist in the diagnosis. Attacks are often precipitated by an intercurrent problem, such as infection or constipation.

Market Analysis:

More than 2 000 million people alive today have been infected with HBV at some time in their lives. Of these, about 350 million remain infected chronically and become carriers of the virus. Three quarters of the world’s population live in areas where there are high levels of infection. Every year there are over 4 million acute clinical cases of HBV, and about 25% of carriers, 1 million people a year, die from chronic active hepatitis, cirrhosis or primary liver cancer. High endemicity areas include sub-Saharan Africa, the Middle East, the central Asian Republics, and some countries in eastern Europe. In these areas, about 70 to 90% of the population becomes HBV-infected before the age of 40, and 8 to 20% of people are HBV carriers. In countries such as China, Senegal, and Thailand, infection rates are very high in infants, and continue through early childhood. At that stage the prevalence of HBsAg in serum may exceed 25%. HBV is well studied in Saudi Arabia where the prevalence in the general population is 4.25%. The genotype of the virus D predominates in the Middle East. The highest prevalence (17.5%) of HCV in the world was reported in Egypt. The pooled prevalence of HCV in haemodialysis patients is 16% in Iran, 56% in Saudi Arabia, 52% in Syria, and 34% in Sudan.

List of Best Conferences:

5th Virology Conference
December 7-09, 2015 Atlanta, USA

2nd Hepatology Conference
May 09-11, 2016 Chicago, USA

Pancreas Conference
May 12-14, 2016 Chicago, USA

6th Gastroenterology and Gastroenterologists Meeting
June 16-18, 2016 Philadelphia, USA

7th Gastroenterologists Meeting
August 11-12, 2016 Birmingham, UK

Clinical Gastroenterology and Hepatology Conference
October 3-5, 2016 Toronto, Canada

3rd Hepatitis and Liver diseases Conference

October 17-19, 2016 Dubai, UAE

European Gastroenterology Conference
October 24-26, 2016 Valencia, Spain

9th Paris Hepatitis Conference

January 11-12, 2016 Paris, France

Asian pacific Association for the study of the liver 2016

February 20-24, 2016 Tokyo, Japan

International Conference on Gastroenterology, Hepatology and Nutrition

February 25-26, 2016 London, UK

The 51st Annual Meeting of the European Association for the Study of the Liver

April 13- 17, Barcelona, Spain

12th World Congress of the International Hepato-Pancreato-Biliary Association

April 19 – 23, 2016, Sao Paolo, Brazil

International Liver Transplantation Society Annual International Congress

May 4 – 7, 2016, Seoul, South Korea

18th International Conference on Hepatology and Liver Disease

May 23 – 24, 2016, London, UK

Prague Hepatology Meeting 2016

September 22 – 24, 2016 Prague, Czech

World Congress of Pediatric Gastroenterology, Hepatology and Nutrition

October 4 – 10, 2016 Montreal, Canada

18th International Conference on Viral Hepatitis

December 12-13, 2016 Bangkok, Thailand

List of Societies and Associations:

  • American Association for the Study of Liver Diseases (AASLD)
  • American Hepato-Pancreato-Biliary Association (AHPBA)
  • American Liver Foundation (ALF)
  • Asian Pacific Association for the Study of the Liver (APASL)
  • European Association for the Study of the Liver (EASL)
  • Hepatitis B Foundation
  • Hepatitis Foundation International
  • International Hepato Pancreato Biliary Association (IHPBA)
  • International Liver Transplantation Society (ILTS)
  • Texas Society for Gastroenterology and Endoscopy
  • International Association for the Study of the Liver (IASL)
  • British Association for the Study of the Liver (BASL)
  • Canadian Association for the Study of the Liver (CASL)
  • Canadian Liver Foundation (CLF)

List of Companies:

  • Astrazeneca
  • Lunatus
  • Pfizer
  • Merck
  • Hikma Pharmaceuticals
  • Elis Pharmaceuticals Limited
  • Sanofi Aventis
  • Ranbaxy Laboratories Limited
  • GlaxoSmithKline
  • Saga Pharmaceuticals
  • Baxter A.G
  • Johnson & Johnson
  • Novo Nordisk Pharma
  • Valeant Pharmaceuticals
  • Amgen
  • Genpharm
  • Hepa Wash GmbH
  • Intrasense
  • Vital Therapies, Inc


This page will be updated regularly.

This page was last updated on 14th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
+1-702-508-5200 Ext:8051

Program Enquiries
Media Partners | Advertising